Long-term outcomes after cytoreductive surgery and HIPEC for morcellated uterine leiomyosarcoma; A case series
Uterine leiomyosarcoma (uLMS) is a rare aggressive malignant mesenchymal tumor with high risk of recurrence and poor prognosis regardless of stage. It is often diagnosed postoperatively following myomectomy, hysterectomy or supracervical hysterectomy for presumed benign disease. Primary surgery at t...
Saved in:
Main Authors: | Maya Yasukawa (Author), Louis A. Dainty (Author), Paul H. Sugarbaker (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of tumor morcellation during surgery in patients with early uterine leiomyosarcoma
by: Kuan-Hung Lin, et al.
Published: (2015) -
Clinical outcome affected by tumor morcellation in unexpected early uterine leiomyosarcoma
by: Kuan-Hung Lin, et al.
Published: (2015) -
Cytoreduction can reduce the recurrence rate of patients with occult uterine sarcoma undergoing morcellation: a retrospective study
by: Chao Ding, et al.
Published: (2022) -
The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis
by: Guyu Zhang, et al.
Published: (2019) -
Leiomyosarcoma after Total Laparoscopic Hysterectomy with Power Morcellation
by: Tsukasa Takahashi, et al.
Published: (2019)